Matt Klingsberg is currently the Global Finance Lead at Pfizer’s Rare Disease Business Unit, a role they have held since 2019. Prior to this, Matt served as the Senior Regional Finance Director for Asia Pacific and held various director positions within Pfizer's financial planning and analysis sectors from 2008 to 2015. They began their career as a Health Care Consultant at KPMG from 1997 to 2000. Matt completed education at both Brandeis University and New York University - Leonard N. Stern School of Business in 1995.
This person is not in any teams
This person is not in any offices